GlassScriptPhysician profile
Brandy Hayes
NPI 1285091892
$1,466.46
in general payments reported to CMS, 2019-2025
18 companies · $796 in 2025
The $796 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.61 · 2023: $176 · 2024: $449 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $446.90 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $179.21 | 2024-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $155.76 | 2023-2025 | Verquvo, Capvaxive |
| Amgen INC. | $116.59 | 2023-2025 | Repatha, Repatha |
| Lexicon Pharmaceuticals, INC. | $111.46 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $100.10 | 2023-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.21 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $47.20 | 2023-2024 | Watchman Flx, Varithena Administration Pack |
| Medtronic, INC. | $42.19 | 2025 | Corevalve Evolut R |
| Bayer Healthcare Pharmaceuticals INC. | $31.98 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $22.03 | 2024 | Arcalyst |
| Altathera Pharmaceuticals LLC | $21.71 | 2025 | Sotalol Hydrochloride |
| Janssen Pharmaceuticals, INC | $19.10 | 2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $18.99 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $18.92 | 2025 | Camzyos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.21 | 2024 | |
| Abiomed | $15.77 | 2025 | |
| Novo Nordisk INC | $13.13 | 2024 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.